Concepedia

Author

Riichiroh Maruyama

National Hospital Organization Kyushu Cancer Center

Also Known As

R Maruyama, R. Maruyama, RIICHIROH MARUYAMA, Riichiroh MARUYAMA, Riichiroh Maruyama

88

Publications

3.3K

Citations

27

H-Index

46

Concepts

All Affiliations

National Hospital Organization Kyushu Cancer CenterKyushu UniversityThe University of Texas Southwestern Medical CenterNippon Steel Yawata Memorial HospitalSouthwestern Medical Center
RM

About

Riichiroh Maruyama is an author at National Hospital Organization Kyushu Cancer Center specializing in medicine, lung cancer, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

14

20

1.1K

2

Health Sciences

6

6

112

3

Cell Biology

3

3

472

4

Anesthesia

1

1

25

5

Immunology

1

1

132

Riichiroh Maruyama

×

44

Publications

3K

Citations

25

H-Index

YearCitations

Phase III Study, V-15-32, of Gefitinib Versus Docetaxel in Previously Treated Japanese Patients With Non–Small-Cell Lung Cancer

Riichiroh Maruyama, Yutaka Nishiwaki, Tomohide Tamura,

Journal of Clinical Oncology

2008

364

Aberrant promoter methylation profile of prostate cancers and its relationship to clinicopathological features.

Riichiroh Maruyama, Shinichi Toyooka, Kiyomi O. Toyooka,

PubMed

2002

326

Smoke exposure, histologic type and geography‐related differences in the methylation profiles of non‐small cell lung cancer

Shinichi Toyooka, Riichiroh Maruyama, Kiyomi O. Toyooka,

International Journal of Cancer

2002

287

DNA methylation profiles of lung tumors.

Shinichi Toyooka, Kiyomi O. Toyooka, Riichiroh Maruyama,

PubMed

2001

231

Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines

Kenichi Harada, Shinichi Toyooka, Anirban Maitra,

Oncogene

2002

225

Aberrant methylation and simian virus 40 tag sequences in malignant mesothelioma.

Shinichi Toyooka, Harvey I. Pass, Narayan Shivapurkar,

PubMed

2001

132

Methylation profiles of sporadic ovarian tumors and nonmalignant ovaries from high-risk women.

Asha Rathi, Arvind K. Virmani, John O. Schorge,

PubMed

2002

120

Inactivation of cyclin D2 gene in prostate cancers by aberrant promoter methylation.

Asha Padar, Ubaradka G. Sathyanarayana, Makoto Suzuki,

PubMed

2003

105

Relationship between early recurrence and micrometastases in the lymph nodes of patients with stage I non-small-cell lung cancer

Riichiroh Maruyama, Kenji Sugio, Tetsuya Mitsudomi,

Journal of Thoracic and Cardiovascular Surgery

1997

103

Hypermethylation of <i>FHIT</i> as a prognostic marker in nonsmall cell lung carcinoma

Riichiroh Maruyama, Kenji Sugio, Ichiro Yoshino,

Cancer

2004

91

Page 1